| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
66,383,000 |
| Market
Cap: |
1.33(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$16.53 - $28.72 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 2 |
| Insider 6 Months : 2 |
| Insider 3/6 Months : 4.3 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Xencor is a clinical-stage biopharmaceutical company focused on discovering and developing engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. Co. is developing a portfolio of clinical-stage XmAb® drug candidates from its protein engineering technology platforms. Co.'s XmAb bispecific Fc drug candidates include: Vudalimab (XmAb717), which is a bispecific antibody that targets PD-1 and CTLA-4 and for patients with metastatic castration-resistant prostate cancer and other solid tumor types; and Plamotamab, which is a bispecific antibody that targets CD20, an antigen on B-cell tumors, and CD3, an activating receptor on T cells.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
53 |
53 |
53 |
53 |
| Total Buy Value |
$1,013 |
$1,013 |
$1,013 |
$1,013 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
1 |
1 |
1 |
1 |
| Total Shares Sold |
101,351 |
146,351 |
179,848 |
214,693 |
| Total Sell Value |
$2,152,463 |
$3,094,133 |
$3,971,419 |
$5,040,525 |
| Total People Sold |
5 |
5 |
5 |
6 |
| Total Sell Transactions |
10 |
11 |
12 |
27 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Desjarlais John R |
Sr. V.P., Research & CSO |
• – – |
2018-08-10 |
4 |
S |
$40.03 |
$595,092 |
D/D |
(14,867) |
88,098 |
|
- |
|
| Baracchini Edgardo Jr |
Chief Business Officer |
• – – |
2018-08-09 |
4 |
S |
$40.35 |
$334,198 |
D/D |
(8,283) |
29,190 |
|
- |
|
| Baracchini Edgardo Jr |
Chief Business Officer |
• – – |
2018-08-09 |
4 |
OE |
$11.05 |
$411,789 |
D/D |
37,266 |
37,473 |
|
- |
|
| Desjarlais John R |
Sr. V.P., Research & CSO |
• – – |
2018-08-09 |
4 |
S |
$40.61 |
$817,629 |
D/D |
(20,133) |
102,965 |
|
- |
|
| Desjarlais John R |
Sr. V.P., Research & CSO |
• – – |
2018-08-09 |
4 |
OE |
$4.25 |
$148,750 |
D/D |
35,000 |
123,098 |
|
- |
|
| Ronin Capital, Llc |
10% Owner |
– – • |
2018-07-17 |
4 |
S |
$41.24 |
$1,505,260 |
I/I |
(36,500) |
5,018,848 |
|
- |
|
| Ronin Capital, Llc |
10% Owner |
– – • |
2018-07-16 |
4 |
S |
$40.67 |
$1,093,535 |
I/I |
(26,888) |
5,055,348 |
|
- |
|
| Ronin Capital, Llc |
10% Owner |
– – • |
2018-07-13 |
4 |
S |
$41.97 |
$2,027,684 |
I/I |
(48,312) |
5,082,236 |
|
- |
|
| Ronin Capital, Llc |
10% Owner |
– – • |
2018-07-12 |
4 |
S |
$39.55 |
$2,293,900 |
I/I |
(58,000) |
5,130,548 |
|
- |
|
| Ronin Capital, Llc |
10% Owner |
– – • |
2018-07-11 |
4 |
S |
$39.63 |
$1,189,177 |
I/I |
(30,007) |
5,188,548 |
|
- |
|
| Ronin Capital, Llc |
10% Owner |
– – • |
2018-07-10 |
4 |
S |
$39.89 |
$2,006,188 |
I/I |
(50,293) |
5,218,555 |
|
- |
|
| Ronin Capital, Llc |
10% Owner |
– – • |
2018-06-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
7,500 |
5,268,848 |
|
- |
|
| Ronin Capital, Llc |
10% Owner |
– – • |
2018-06-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,500 |
0 |
|
- |
|
| Ronin Capital, Llc |
10% Owner |
– – • |
2018-06-20 |
4 |
S |
$40.05 |
$3,715,799 |
I/I |
(92,779) |
5,261,348 |
|
- |
|
| Ronin Capital, Llc |
10% Owner |
– – • |
2018-06-19 |
4 |
S |
$39.77 |
$4,114,366 |
I/I |
(103,454) |
5,354,127 |
|
- |
|
| Ronin Capital, Llc |
10% Owner |
– – • |
2018-06-18 |
4 |
S |
$39.88 |
$2,144,228 |
I/I |
(53,767) |
5,457,581 |
|
- |
|
| Dahiyat Bassil I |
President and CEO |
• • – |
2018-06-15 |
4 |
OE |
$4.25 |
$212,500 |
D/D |
50,000 |
343,067 |
|
- |
|
| Dahiyat Bassil I |
President and CEO |
• • – |
2018-06-15 |
4 |
S |
$40.51 |
$2,025,690 |
D/D |
(50,000) |
293,067 |
|
- |
|
| Kuch John J |
Sr. Vice President & CFO |
• – – |
2018-06-13 |
4 |
OE |
$4.25 |
$152,375 |
D/D |
35,853 |
92,482 |
|
- |
|
| Kuch John J |
Sr. Vice President & CFO |
• – – |
2018-06-13 |
4 |
S |
$41.64 |
$1,040,945 |
D/D |
(25,000) |
56,629 |
|
- |
|
| Baracchini Edgardo Jr |
Chief Business Officer |
• – – |
2018-03-15 |
4 |
S |
$30.89 |
$1,235,744 |
D/D |
(40,000) |
0 |
|
- |
|
| Baracchini Edgardo Jr |
Chief Business Officer |
• – – |
2018-03-15 |
4 |
OE |
$0.59 |
$23,600 |
D/D |
40,000 |
40,000 |
|
- |
|
| Baracchini Edgardo Jr |
Chief Business Officer |
• – – |
2018-03-05 |
4 |
AS |
$29.58 |
$295,840 |
D/D |
(10,000) |
0 |
|
- |
|
| Baracchini Edgardo Jr |
Chief Business Officer |
• – – |
2018-03-05 |
4 |
OE |
$0.59 |
$5,900 |
D/D |
10,000 |
10,000 |
|
- |
|
| Baracchini Edgardo Jr |
Chief Business Officer |
• – – |
2018-03-02 |
4 |
AS |
$29.60 |
$295,966 |
D/D |
(10,000) |
0 |
|
- |
|
312 Records found
|
|
Page 6 of 13 |
|
|
0.75 (3.9%) 
